Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$754,376
-$82,958 QoQ
Shares Held
5,971
-0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,202
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. GILD ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,810 | $334,772 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $754,376 | 5,971 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $837,334 | 6,008 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $700,968 | 5,711 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $570,318 | 5,138 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $546,478 | 4,929 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $512,516 | 4,574 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $426,841 | 4,621 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $388,514 | 4,634 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $319,379 | 4,655 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $373,355 | 5,097 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,133,410 | 13,991 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,008,092 | 13,452 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,046,379 | 13,577 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $1,602,731 | 19,317 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $1,725,413 | 20,098 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $1,192,714 | 19,334 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $1,153,869 | 18,668 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $860,895 | 14,481 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $284,736 | 4,135 | Shares | Sole | 2023-12-13 | |
| 2021-03-31 | $278,167 | 4,304 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $293,805 | 5,043 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $318,667 | 5,043 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $501,417 | 6,517 | Shares | Sole | 2021-05-18 | |
| 2020-03-31 | $367,819 | 4,920 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||